-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCENTAGE PHARMA ANNOUNCES INCLUSION OF LISAFTOCLAX IN CHINA'S 2026 NATIONAL REIMBURSEMENT DRUG LIST AND SUCCESSFUL RENEWAL OF COVERAGE FOR OLVEREMBATINIB

Reuters·11/15/2026 23:30:00

Please log in to view news